Founded in early 2005, StratiCELL is a leading company assisting the cosmetic, pharmaceutical and chemical industries to the safety and efficacy evaluation of their actives and products by means of in vitro models and methods in a GLP-compliant environment.
StratiCELL is a skin model manufacturer and a project-driven services provider for in vitro testing, with a particular emphasis on testing of skin care actives and products
Regulatory Toxicity (OECD, REACH)
All substances, whether used in a pharmaceutical, cosmetic, or chemical application, have to comply with stringent regulations guaranteeing consumer protection and the well-being of industry employees.
Globally, with Europe as a trendsetter, alternatives to animal testing are promoted where possible for the safety evaluation. Consequently, alternative methods, whenever available and validated, are required by the legal authorities for toxicity assessment. This is the case for instance for the EU regulation No 1970/2006 better known as REACH (Registration, Evaluation, Authorization, and restriction of Chemicals), which has its impact on substances produced in the EU and on substances imported in the EU. For the evaluation of cosmetic ingredients and finished products the EU goes even further by banning all animal testing in its 7th amendment of the Cosmetic Directive 76/768/EEC.
With the program "REACH-it with in vitro testing", StratiCELL aims to be, among its other in vitro testing activities, the reference service provider for regulatory in vitro safety testing.
StratiCELL offers the full panel of in vitro tests under the different EU legislations, and has therefore implemented validated, valid, and scientifically accepted in vitro toxicity tests described by international guidelines (OECD, ECVAM, ICCVAM, ICH, ...) for the safety assessment of a substance.
StratiCELL presently works in a GLP-like environment (Formal accreditation is ongoing).

An overview of the regulatory in vitro toxicity tests
|
![]() |








